Pharmacokinetics of nimustine, methotrexate, and cytosine arabinoside during cerebrospinal fluid perfusion chemotherapy in patients with disseminated brain tumors

被引：0
|
作者：
N. Morikawa
T. Mori
H. Kawashima
M. Fujiki
T. Abe
T. Kaku
Y. Konisi
M. Takeyama
S. Hori
机构：
[1] Department of Clinical Pharmacy,
[2] Oita Medical University,undefined
[3] Hasama-machi,undefined
[4] Oita 879-55,undefined
[5] Japan Tel.: 975-49-4411 (Ext. 6101) Fax: 975-86-6119,undefined
[6] Department of Neurosurgery,undefined
[7] Oita Medical University,undefined
[8] Oita,undefined
[9] Japan,undefined
来源：
European Journal of Clinical Pharmacology | 1998年 / 54卷
关键词：
Key words Cerebrospinal fluid perfusion; Chemotherapy; Brain tumor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Objective: This study was conducted to evaluate the pharmacokinetics of anticancer drugs in cerebrospinal fluid (CSF) perfusion chemotherapy.
引用
收藏
页码：415 / 420
页数：5
相关论文
共 50 条
  • [1] Pharmacokinetics of nimustine, methotrexate, and cytosine arabinoside during cerebrospinal fluid perfusion chemotherapy in patients with disseminated brain tumors
    Morikawa, N
    Mori, T
    Kawashima, H
    Fujiki, M
    Abe, T
    Kaku, T
    Konisi, Y
    Takeyama, N
    Hori, S
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 54 (05) : 415 - 420
  • [2] Pharmacokinetics of nimustine, cytosine arabinoside, and methotrexate in cerebrospinal fluid during cerebrospinal fluid perfusion chemotherapy
    Morikawa, N
    Mori, T
    Kawashima, H
    Takeyama, M
    Abe, T
    Kobayashi, H
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2001, 24 (04) : 436 - 438
  • [3] Pharmacokinetics of cytosine arabinoside, methotrexate, nimustine and valproic acid in cerebrospinal fluid during cerebrospinal fluid perfusion chemotherapy
    Morikawa, N
    Mori, T
    Abe, T
    Kawashima, H
    Takeyama, M
    Hori, S
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2000, 23 (06) : 784 - 787
  • [4] PLASMA AND CEREBROSPINAL-FLUID PHARMACOKINETICS OF CYTOSINE-ARABINOSIDE IN DOGS
    SCOTTMONCRIEFF, JCR
    CHAN, TCK
    SAMUELS, ML
    COOK, JR
    COPPOC, GL
    DENICOLA, DB
    RICHARDSON, RC
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1991, 29 (01) : 13 - 18
  • [5] Ventriculolumbar perfusion chemotherapy with methotrexate and cytosine arabinoside for meningeal carcinomatosis: A pilot study in 13 patients
    Nakagawa, H
    Fujita, T
    Kubo, S
    Izumoto, S
    Nakajima, Y
    Tsuruzono, K
    Tokiyoshi, K
    Hayakawa, T
    SURGICAL NEUROLOGY, 1996, 45 (03): : 256 - 263
  • [6] Ventriculolumbar perfusion chemotherapy with methotrexate and cytosine arabinoside for meningeal carcinomatosis: A pilot study in 13 patients - Commentary
    Shapiro, WR
    SURGICAL NEUROLOGY, 1996, 45 (03): : 263 - 264
  • [7] METHOTREXATE, CYTOSINE-ARABINOSIDE, AND BCNU CONCENTRATION IN BRAIN AFTER VENTRICULOCISTERNAL PERFUSION
    BLASBERG, RG
    CANCER TREATMENT REPORTS, 1977, 61 (04): : 625 - 631
  • [8] CEREBROSPINAL-FLUID (CSF) PHARMACOKINETICS OF CYTOSINE-ARABINOSIDE (ARA-C)
    LOPEZ, JA
    KRIKORIAN, JG
    BEARDSLEY, GP
    AGARWAL, RP
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 210 - 210
  • [9] THE PHARMACOKINETICS OF CYTOSINE-ARABINOSIDE IN THE PLASMA AND CEREBROSPINAL-FLUID DURING CONVENTIONAL AND HIGH-DOSE THERAPY
    SLEVIN, ML
    PIALL, EM
    AHERNE, GW
    JOHNSTON, A
    LISTER, TA
    MEDICAL AND PEDIATRIC ONCOLOGY, 1982, : 157 - 168
  • [10] PHARMACOKINETICS OF CYTOSINE-ARABINOSIDE IN CEREBROSPINAL-FLUID AND OF ITS METABOLITE IN LEUKEMIC-CELLS
    BEKASSY, AN
    LILIEMARK, J
    GARWICZ, S
    WIEBE, T
    GULLIKSSON, H
    PETERSON, C
    MEDICAL AND PEDIATRIC ONCOLOGY, 1990, 18 (02): : 136 - 142
12345